Patents by Inventor Yoshikazu MIYAZAKI

Yoshikazu MIYAZAKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132738
    Abstract: The present invention provides a polymeric dispersant that is to be blended in an aqueous pigment dispersion in which a pigment is finely dispersed in a stable manner and at a high level, the aqueous pigment dispersion enabling preparation of an aqueous inkjet ink capable of recording an image excellent in adhesiveness and durability on plastic media and textiles. The polymeric dispersant is a polymer that includes a constituent unit (i) derived from styrene, a constituent unit (ii) derived from methyl methacrylate and/or the like, a constituent unit (iii) derived from 2-ethylhexyl methacrylate and/or the like, a constituent unit (iv) derived from 2-hydroxyethyl methacrylate and/or the like, and a constituent unit (v) derived from methacrylic acid, and at least part of carboxy groups is neutralized with an alkali.
    Type: Application
    Filed: November 26, 2021
    Publication date: April 25, 2024
    Inventors: Hiroyuki SHIMANAKA, Katsuhiko KANO, Kosuke KUME, Chikako MIYAZAKI, Yoshikazu MURAKAMI, Sachio YOSHIKAWA
  • Patent number: 10154993
    Abstract: [Problem] To provide a novel pharmaceutical composition which can suppress delayed, release of the compound represented in general formula (1) or a salt thereof. [Solution] This solid pharmaceutical composition contains the compound represented in general formula (1), or a salt thereof, and a salting-out agent.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: December 18, 2018
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Hiroshi Uchida, Masataka Hanada, Yoshikazu Miyazaki
  • Publication number: 20170319571
    Abstract: [Problem] To provide a novel pharmaceutical composition which can suppress delayed, release of the compound represented in general formula (1) or a salt thereof. [Solution] This solid pharmaceutical composition contains the compound represented in general formula (1), or a salt thereof, and a salting-out agent.
    Type: Application
    Filed: October 23, 2015
    Publication date: November 9, 2017
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Hiroshi UCHIDA, Masataka HANADA, Yoshikazu MIYAZAKI
  • Patent number: 9687453
    Abstract: [Problem] To provide a novel pharmaceutical composition which contains a medically active component and which can suppress delays in the release of said component due to gelling. [Solution] This solid pharmaceutical composition contains a compound represented by general formula (1), or a salt thereof, a cellulosic excipient, and a salting-out agent.
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: June 27, 2017
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Hiroshi Uchida, Masataka Hanada, Yoshikazu Miyazaki
  • Publication number: 20160074330
    Abstract: [Problem] To provide a novel pharmaceutical composition which contains a medically active component and which can suppress delays in the release of said component due to gelling. [Solution] This solid pharmaceutical composition contains a compound represented by general formula (1), or a salt thereof, a cellulosic excipient, and a salting-out agent.
    Type: Application
    Filed: April 24, 2014
    Publication date: March 17, 2016
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Hiroshi UCHIDA, Masataka HANADA, Yoshikazu MIYAZAKI